Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant changes » significant challenge (Expand Search)
significant green » significant degrees (Expand Search), significant burden (Expand Search), significant genes (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant changes » significant challenge (Expand Search)
significant green » significant degrees (Expand Search), significant burden (Expand Search), significant genes (Expand Search)
-
1201
-
1202
Comparison of adhesiveness ranges for different food categories under IDDSI levels.
Published 2025Subjects: -
1203
-
1204
-
1205
Statistical analysis of adhesiveness, hardness, and cohesiveness across IDDSI levels.
Published 2025Subjects: -
1206
Comparison of hardness ranges for different food categories under IDDSI levels.
Published 2025Subjects: -
1207
-
1208
-
1209
-
1210
-
1211
-
1212
-
1213
Changes in the white blood cell count.
Published 2025“…The leukocyte and neutrophil counts of the patients in the bone pain group were significantly higher than those of the patients in the no bone pain group, P(WBC) = 0.001, P(ANC) = 0.002.…”
-
1214
-
1215
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
1216
-
1217
-
1218
-
1219
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
1220
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”